Axsome Therapeutics, Inc.(AXSM)
A biopharmaceutical company that acquired the rights to Sunosi (solriamfetol).
1 Insight
Investment Insights
AI-generated insights about Axsome Therapeutics, Inc. from various financial sources
Monday, March 9, 2026
Bullish
Sunosi is showing promise for ADHD with a gentler effect profile than traditional stimulants like Adderall.
Monday, March 9, 2026
Bullish
Sunosi is showing promise for ADHD with a gentler effect profile than traditional stimulants like Adderall.